Outlook Therapeutics, Inc. (OTLK)

Outlook Therapeutics Market Cap

Outlook Therapeutics has a market cap or net worth of $181.96 million as of April 26, 2024. Its market cap has decreased by -38.36% in one year.

• Market Cap: 181.96M
• Enterprise Value: 208.14M
• 1-Year Change: -38.36%
• Ranking: #3720
• Category: Micro-Cap
• Stock Price: $8.43

Market Cap Chart

Since June 14, 2016, Outlook Therapeutics's market cap has increased from $97.40M to $181.96M, an increase of 86.81%. That is a compound annual growth rate of 8.27%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	106.60M	-0.09%
Apr 24, 2024	106.70M	-
Apr 23, 2024	106.70M	1.33%
Apr 22, 2024	105.30M	-0.94%
Apr 19, 2024	106.30M	-1.48%
Apr 18, 2024	107.90M	-3.66%
Apr 17, 2024	112.00M	-1.67%
Apr 16, 2024	113.90M	1.52%
Apr 15, 2024	112.20M	-0.88%
Apr 12, 2024	113.20M	-3.74%
Apr 11, 2024	117.60M	0.51%
Apr 10, 2024	117.00M	-2.90%
Apr 9, 2024	120.50M	-0.99%
Apr 8, 2024	121.70M	1.00%
Apr 5, 2024	120.50M	-2.74%
Apr 4, 2024	123.90M	4.38%
Apr 3, 2024	118.70M	-5.94%
Apr 2, 2024	126.20M	-5.47%
Apr 1, 2024	133.50M	-14.09%
Mar 28, 2024	155.40M	27.48%
Mar 27, 2024	121.90M	7.88%
Mar 26, 2024	113.00M	2.08%
Mar 25, 2024	110.70M	-1.42%
Mar 22, 2024	112.30M	22.60%
Mar 21, 2024	91.60M	3.85%

View and export this data all the way back to 2016. Sign Up Today.

Related Stocks

Company	Market Cap
INmune Bio	184.58M
OrganiGram Holdings	183.49M
908 Devices	182.98M
Omeros	179.04M
Compugen	177.27M
Kodiak Sciences	174.85M
Alpha Tau Medical	174.18M
Candel Therapeutics	173.44M